Chemotherapy better tolerated when matched to body's rhythmBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7109.623j (Published 13 September 1997) Cite this as: BMJ 1997;315:623
- Zosia Kmietowicz
Giving chemotherapy as a variable infusion that mimics circadian rhythms rather than as a constant infusion reduces fivefold the adverse events in patients with colorectal cancer, according to the results of a randomised trial. The technique of variable drug infusion, known as chronotherapy, may benefit all patients with cancer requiring drug therapy by improving response and tolerance, believe French researchers.
In their trial the investigators assigned 186 patients with previously untreated metastases from colorectal …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial